Literature DB >> 18798003

Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans.

Sang-Yong Eom1, Yan Wei Zhang, Sung-Hoon Kim, Kang-Hyeon Choe, Kye Young Lee, Jung-Duck Park, Yun-Chul Hong, Yong-Dae Kim, Jong-Won Kang, Heon Kim.   

Abstract

OBJECTIVES: We investigated the association of genetic polymorphisms of NQO1, ALDH2, CYP2E1, and the combined genotype of these genes on lung cancer risk, and also evaluated the association after stratification by cumulative smoking amounts and alcohol drinking levels.
METHODS: The case-control study was performed in 387 lung cancer patients and 387 age- and sex-matched cancer-free controls. Direct interview was conducted and the genotypes of NQO1, ALDH2, and CYP2E1 were investigated using PCR-RFLP or 5'-nuclease activity assay.
RESULTS: The proportion of individuals with occupational history of mining was significantly higher in cases than in controls. The risk of lung cancer was significantly lower in light-drinkers (<108 g/week) than non-drinkers. The NQO1 Pro/Ser + Ser/Ser genotype showed an increased risk for lung cancer with a marginal significance (OR = 1.35, 95% CI = 0.99-1.86) compared with NQO1 Pro/Pro genotype. In heavy-smokers, the combination of NQO1 Pro/Ser + Ser/Ser and CYP2E1 c1/c1 genotype was associated with a significantly increased risk for lung cancer (OR = 2.25, 95% CI = 1.14-4.43) compared with those of NQO1 Pro/Pro and CYP2E1 c1/c2 + c2/c2 genotype. We found a significant interaction between alcohol drinking level and the CYP2E1 genotype (P = 0.0227).
CONCLUSIONS: Our result suggests that the risk of lung cancer is affected by smoking, alcohol drinking, and the genetic polymorphism of NQO1. In particular, genetic polymorphisms for NQO1, CYP2E1, and ALDH2 synergistically with cumulative smoking amounts and alcohol drinking levels interact in the carcinogenesis of lung cancer in Koreans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798003     DOI: 10.1007/s10552-008-9225-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  17 in total

1.  Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues.

Authors:  Satori A Marchitti; David J Orlicky; Chad Brocker; Vasilis Vasiliou
Journal:  J Histochem Cytochem       Date:  2010-09       Impact factor: 2.479

2.  Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Liang Song; Ling Peng; Zhibin Bu; Sen-Xiang Yan; Jie Feng; Xin-Li Zhu; Xin-Biao Liao; Xue-Lin Yu; Danfang Yan
Journal:  Mol Genet Genomics       Date:  2014-10-22       Impact factor: 3.291

3.  Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan.

Authors:  Yuzo Yamamoto; Chikako Kiyohara; Saiko Suetsugu-Ogata; Naoki Hamada; Yoichi Nakanishi
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

4.  Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.

Authors:  Xiu-Lan Su; Ba Bin; Hong-Wei Cui; Mei-Rong Ran
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

5.  Association between cytochrome P450 promoter polymorphisms and ischemic stroke.

Authors:  Su Kang Kim; Sung-Vin Yim; Byung-Cheol Lee
Journal:  Exp Ther Med       Date:  2011-11-22       Impact factor: 2.447

6.  NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.

Authors:  Yuqing Lou; Rong Li; Liwen Xiong; Aiqin Gu; Chunlei Shi; Tianqing Chu; Xueyan Zhang; Ping Gu; Hua Zhong; Shaojun Wen; Baohui Han
Journal:  Tumour Biol       Date:  2013-07-14

7.  Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.

Authors:  Shujie Guo; Min Gao; Xiaobo Li; Yuqiong Li; Shaoli Chu; Dingliang Zhu; Wenquan Niu
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

8.  Association between Glu504Lys polymorphism of ALDH2 gene and cancer risk: a meta-analysis.

Authors:  Qiang Cai; Jian Wu; Qu Cai; Er-Zhen Chen; Zhao-Yan Jiang
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

9.  CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.

Authors:  Ze-Tian Shen; Xin-Hu Wu; Bing Li; Jun-shu Shen; Zhen Wang; Jing Li; Xi-Xu Zhu
Journal:  J Cell Mol Med       Date:  2015-05-06       Impact factor: 5.310

Review 10.  The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment.

Authors:  Hong Zhang; Liwu Fu
Journal:  Acta Pharm Sin B       Date:  2021-02-11       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.